FDBusiness.com

New Medicine to Protect Honey Bees Against Varroa Mites

 Breaking News
  • Nestlé Inaugurates New Nescafé Dolce Gusto Production in Vietnam Nestlé has inaugurated a new Nescafé Dolce Gusto capsule production line in Dong Nai Province, Vietnam. The site will process an expected 2,500 tons of coffee per year (equivalent to 130 million capsules), using high quality coffee beans from Vietnam. This volume is expected to increase in the coming years. The investment reflects Nestlé’s clear focus on high-growth, [...]...
  • Pink Lemonade Yogurt? Arla Brings Indulgence to New Markets Arla Foods is to expand its successful Finnish brand, Ihana, into new markets with the premium yogurt range being launched in Denmark and the UK. Meaning ‘wonderful’ in Finnish, Ihana was launched through an extensive brand launch in 2016 in Finland with an iconic new design. Indulgence is one of the few areas in growth within [...]...
  • Process Components Announces Kemutec Expansion into Netherlands Process Components has announced the expansion of subsidiary company Kemutec in Europe, with the long-established manufacturing brand opening a new office in the Netherlands. The move forms a key part of its global strategy to extend its global territories, significantly grow its revenues and create new jobs. Kemutec has more than three decades’ worth of heritage in [...]...
  • Packaging Automation Supports the Reduction in Plastic Packaging Waste With the launch of the UK Plastics Pact to address the impact plastic waste is having on the environment, retailers and manufacturers are more conscious of single use and non-recyclable plastics and want to cater for the green consumer. The industry is turning to various kinds of eco-friendly packaging with the aim of reducing plastic [...]...
  • Glanbia Cheese Joint Venture to Build New €130 Million Mozzarella Cheese Facility Glanbia Cheese, the joint venture business between Glanbia plc and Leprino Foods, plans to build a new, world-class mozzarella cheese manufacturing facility in Portlaoise, County Laois, Ireland. A site for the new facility has been identified at the recently established Togher National Industrial Estate in Portlaoise. A total of €130 million will be invested in [...]...

New Medicine to Protect Honey Bees Against Varroa Mites

New Medicine to Protect Honey Bees Against Varroa Mites
October 12
09:34 2016

The Committee for Medicinal Products for Veterinary Use (CVMP) of the European Medicines Agency (EMA) has recommended the granting of a marketing authorisation in the European Union (EU) for VarroMed (oxalic acid dihydrate/formic acid). This antiparasitic medicine treats the Varroa mite infestation in honey-bee colonies, which is considered to be the most significant parasitic health concern affecting honey bees worldwide.

Honey bees are essential for pollination of crops and wild plants in Europe. The European Commission estimates that pollinators, including honey bees, bumble bees and wild bees, contribute at least Eur22 billion each year to European agriculture and pollinate over 80% of crops and wild plants on the continent.

However, beekeepers around the world have reported losses of honey-bee colonies, which are considered to be caused by a combination of different factors such as habitat loss, climate change, pesticide use, and also diseases affecting bee health. A continued decline of these pollinators could lead to serious biological, agricultural, environmental and economic difficulties.

The main parasite affecting honey bees is the Varroa mite (Varroa destructor), an invasive species from Asia that has affected bee colonies worldwide. The Varroa mite feeds on the circulatory fluid of bees and brood (bee larvae) and can also contribute to the spread of viruses and bacteria.

VarroMed is intended to kill Varroa mites and is a liquid which is trickled onto bees in the hive. It contains as active substance a fixed combination of two organic acids, oxalic acid dihydrate and formic acid. Both substances have been known in veterinary medicine for a long time and are either naturally present in foods or accepted for use in foods. The medicine is not expected to pose a risk to human or animal health or the environment, if used according to the product information.

VarroMed is intended to be used as part of an integrated Varroa control programme, which includes not only treatment with medicines but also non-chemical techniques like queen trapping or drone brood removal. It can be used either as a single-dose treatment during the broodless period (winter treatment) or in the presence of brood (spring or autumn), which will usually require repeated treatments.

The CVMP opinion will now be sent to the European Commission for the adoption of a decision on an EU-wide marketing authorisation.

About Author

mike

mike



Food & Drink Business Conference & Exhibition 2016

Upcoming Events

  • September 5, 2018Int'l Food Products and Processing Technologies Exhibition (WorldFood Istanbul)
  • September 15, 2018iba
  • September 25, 2018PPMA Show 2018
  • September 27, 2018Int'l Fruit Show (eurofruit)
AEC v1.0.4

find food jobs

The Magazine

F&D Business Preferred Suppliers

New Subscriber





Subscribe Here



Advertisements